Biopower Operations Valuation

BOPO Stock  USD 0.0001  0.00  0.00%   
Biopower Operations seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Biopower Operations Corp from analyzing the firm fundamentals such as Return On Asset of -1.41, operating margin of (0.36) %, and Shares Outstanding of 45.62 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.0001
Please note that Biopower Operations' price fluctuation is very steady at this time. Calculation of the real value of Biopower Operations Corp is based on 3 months time horizon. Increasing Biopower Operations' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biopower Operations is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biopower Pink Sheet. However, Biopower Operations' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.0E-4 Real  8.4E-5 Hype  1.0E-4
The intrinsic value of Biopower Operations' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biopower Operations' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.000084
Real Value
0.00
Upside
Estimating the potential upside or downside of Biopower Operations Corp helps investors to forecast how Biopower pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biopower Operations more accurately as focusing exclusively on Biopower Operations' fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details

Biopower Operations Total Value Analysis

Biopower Operations Corp is currently projected to have valuation of 5.65 M with market capitalization of 4.56 M, debt of 3.41 M, and cash on hands of 522.36 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biopower Operations fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
5.65 M
4.56 M
3.41 M
522.36 K

Biopower Operations Investor Information

About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Biopower Operations Corp had not issued any dividends in recent years. The entity had 1:5 split on the 4th of September 2013. Based on the key indicators related to Biopower Operations' liquidity, profitability, solvency, and operating efficiency, Biopower Operations Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.

Biopower Operations Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biopower Operations has an asset utilization ratio of 182.34 percent. This suggests that the Company is making $1.82 for each dollar of assets. An increasing asset utilization means that Biopower Operations Corp is more efficient with each dollar of assets it utilizes for everyday operations.

Biopower Operations Ownership Allocation

Biopower Operations holds a total of 45.62 Million outstanding shares. Biopower Operations Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Biopower Operations Profitability Analysis

The company reported the previous year's revenue of 175 K. Net Loss for the year was (129.75 K) with profit before overhead, payroll, taxes, and interest of 175 K.

About Biopower Operations Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Biopower Operations Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Biopower Operations Corp based exclusively on its fundamental and basic technical indicators. By analyzing Biopower Operations's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Biopower Operations's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biopower Operations. We calculate exposure to Biopower Operations's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biopower Operations's related companies.
BioPower Operations Corporation, through its subsidiaries, focuses on operating HyFi Platform. The company was incorporated in 2010 and is based in Aventura, Florida. Biopower Operations operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 1 people.

8 Steps to conduct Biopower Operations' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biopower Operations' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biopower Operations' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Biopower Operations' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Biopower Operations' revenue streams: Identify Biopower Operations' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Biopower Operations' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Biopower Operations' growth potential: Evaluate Biopower Operations' management, business model, and growth potential.
  • Determine Biopower Operations' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biopower Operations' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Biopower Operations Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding43.1 M
Retained Earnings-9.1 M

Other Information on Investing in Biopower Pink Sheet

Biopower Operations financial ratios help investors to determine whether Biopower Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biopower with respect to the benefits of owning Biopower Operations security.